Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

KCI Notches Partial Victory Against Smith & Nephew In German Patent Suit

This article was originally published in The Gray Sheet

Executive Summary

Kinetic Concepts Inc. continued its string of patent victories against negative pressure wound therapy competitor Smith & Nephew in Germany last week, but the decision was more mixed than other recent rulings

You may also be interested in...



KCI wins injunction against Smith & Nephew in U.K.

A U.K. patent court has entered an injunction against Smith & Nephew, prohibiting it from infringing on two Kinetic Concepts Inc. negative pressure wound therapy patents, though the injunction is stayed pending appeal. The court ruled in June that sales of Smith & Nephew's Renasys NPWT products infringe on two KCI patents. Smith & Nephew noted in a July 30 press release that the Renasys products will continue on the U.K. market pending an appeals court review. KCI, maker of the competing V.A.C. therapy products, won a related victory over Smith & Nephew in a recent U.S. lawsuit (1"The Gray Sheet" March 15, 2010)

KCI Wins Negative Pressure Wound Therapy Patent Suit Over Smith & Nephew

V.A.C. maker Kinetic Concepts claimed victory over Smith & Nephew in a long-standing negative pressure wound therapy patent infringement suit, but Smith & Nephew plans to appeal the verdict

Coronavirus Update: UK Calls For COVID-19 Patients To Join Trials

GSK creates another partnership centered on its vaccine adjuvant technology, this time with China's Xiamen Innovax.

Topics

UsernamePublicRestriction

Register

MT029284

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel